MedDataX Logo

Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians

NCT ID: NCT01777074

Last Updated: 2013-02-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

474 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-11-30

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study is conducted in order to assess the acceptability of Hepatitis B vaccination in French general practitioners and peadiatricians before and after reimbursement of the paediatric vaccine InfanrixHexa. Two data measurement time points are planned, first before reimbursement and after reimbursement.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Acceptability of Hepatitis B Vaccination in General Population

NCT01782794

Hepatitis B
COMPLETED

A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA

NCT00693186

Hepatitis B
COMPLETED PHASE3

Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age

NCT02610348

Hepatitis B
COMPLETED NA

Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children

NCT04294433

Hepatitis B
COMPLETED PHASE4

Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine

NCT00289796

Hepatitis B
COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the study is to assess the acceptability of Hepatitis B immunization among general practitioners and open-care paediatricians. This is a national, repeated transversal epidemiological study with two data measurement time-points over a period of two years (T1 in 2009, T2 in 2011, two different samples of physicians) in order to assess immunization practices before introduction of the reimbursement of InfanrixHexa®, during the transition period and then during the period following reimbursement of the vaccine. At each collection time-point, two patient age groups will be investigated: 12-15 months and 24-27 months, thus providing measurements before/after reimbursement.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatitis B

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Generalist physicians Cohort

Data collection

Intervention Type OTHER

Questionnaire, Vaccination book

Paediatricians Cohort

Data collection

Intervention Type OTHER

Questionnaire, Vaccination book

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Data collection

Questionnaire, Vaccination book

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• Children on the eligibility register complying with the investigator's immunization policy (children followed by the investigator since their birth, whose immunization regimen has been managed by the investigator).

Exclusion Criteria

* Children on the eligibility register not complying with the investigator's immunization policy.
* Refusal of the patient.
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

GlaxoSmithKline

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

GSK Clinical Trials

Role: STUDY_DIRECTOR

GlaxoSmithKline

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

GSK Investigational Site

Agde, , France

Site Status

GSK Investigational Site

Agen, , France

Site Status

GSK Investigational Site

Agen, , France

Site Status

GSK Investigational Site

Aire-sur-la-Lys, , France

Site Status

GSK Investigational Site

Aizenay, , France

Site Status

GSK Investigational Site

Albi, , France

Site Status

GSK Investigational Site

Alès, , France

Site Status

GSK Investigational Site

Alleins, , France

Site Status

GSK Investigational Site

Amiens, , France

Site Status

GSK Investigational Site

Ancenis, , France

Site Status

GSK Investigational Site

Andrésy, , France

Site Status

GSK Investigational Site

Angers, , France

Site Status

GSK Investigational Site

Anglet, , France

Site Status

GSK Investigational Site

Annecy, , France

Site Status

GSK Investigational Site

Annecy-le-Vieux, , France

Site Status

GSK Investigational Site

Antony, , France

Site Status

GSK Investigational Site

Argenteuil, , France

Site Status

GSK Investigational Site

Arles, , France

Site Status

GSK Investigational Site

Arnas, , France

Site Status

GSK Investigational Site

Arsac, , France

Site Status

GSK Investigational Site

Asnières-sur-Seine, , France

Site Status

GSK Investigational Site

Aubagne, , France

Site Status

GSK Investigational Site

Aubergenville, , France

Site Status

GSK Investigational Site

Aubervilliers, , France

Site Status

GSK Investigational Site

Aucamville, , France

Site Status

GSK Investigational Site

Auchy-les-Mines, , France

Site Status

GSK Investigational Site

Auriol, , France

Site Status

GSK Investigational Site

Avignon, , France

Site Status

GSK Investigational Site

Bagneux, , France

Site Status

GSK Investigational Site

Bagnols-sur-Cèze, , France

Site Status

GSK Investigational Site

Bar-le-Duc, , France

Site Status

GSK Investigational Site

Barr, , France

Site Status

GSK Investigational Site

Beaulieu-lès-Loches, , France

Site Status

GSK Investigational Site

Beaumont, , France

Site Status

GSK Investigational Site

Beaupréau, , France

Site Status

GSK Investigational Site

Beausoleil, , France

Site Status

GSK Investigational Site

Beauvais, , France

Site Status

GSK Investigational Site

Belfort, , France

Site Status

GSK Investigational Site

Bellegarde, , France

Site Status

GSK Investigational Site

Berre-l'Étang, , France

Site Status

GSK Investigational Site

Besançon, , France

Site Status

GSK Investigational Site

Betton, , France

Site Status

GSK Investigational Site

Béthune, , France

Site Status

GSK Investigational Site

Béziers, , France

Site Status

GSK Investigational Site

Biarritz, , France

Site Status

GSK Investigational Site

Bièvres, , France

Site Status

GSK Investigational Site

Biganos, , France

Site Status

GSK Investigational Site

Biscarrosse, , France

Site Status

GSK Investigational Site

Bischheim, , France

Site Status

GSK Investigational Site

Bois-Guillaume, , France

Site Status

GSK Investigational Site

Bollène, , France

Site Status

GSK Investigational Site

Boos, , France

Site Status

GSK Investigational Site

Bordeaux, , France

Site Status

GSK Investigational Site

Bordeaux, , France

Site Status

GSK Investigational Site

Bosmie-l'Aiguille, , France

Site Status

GSK Investigational Site

Boulogne-Billancourt, , France

Site Status

GSK Investigational Site

Bourg-en-Bresse, , France

Site Status

GSK Investigational Site

Bousse, , France

Site Status

GSK Investigational Site

Brest, , France

Site Status

GSK Investigational Site

Bron, , France

Site Status

GSK Investigational Site

Bron, , France

Site Status

GSK Investigational Site

Bruges, , France

Site Status

GSK Investigational Site

Buchy, , France

Site Status

GSK Investigational Site

Caen, , France

Site Status

GSK Investigational Site

Cambrai, , France

Site Status

GSK Investigational Site

Camphin-en-Carembault, , France

Site Status

GSK Investigational Site

Cannes, , France

Site Status

GSK Investigational Site

Carresse-Cassaber, , France

Site Status

GSK Investigational Site

Caveirac, , France

Site Status

GSK Investigational Site

Cergy, , France

Site Status

GSK Investigational Site

Cergy Saint Christophe, , France

Site Status

GSK Investigational Site

Cestas, , France

Site Status

GSK Investigational Site

Chalamont, , France

Site Status

GSK Investigational Site

Challans, , France

Site Status

GSK Investigational Site

Chalon-sur-Saône, , France

Site Status

GSK Investigational Site

Chambly, , France

Site Status

GSK Investigational Site

Champigny-sur-Marne, , France

Site Status

GSK Investigational Site

Chanteloup-les-Vignes, , France

Site Status

GSK Investigational Site

Chantilly, , France

Site Status

GSK Investigational Site

Chartres, , France

Site Status

GSK Investigational Site

Chassieu, , France

Site Status

GSK Investigational Site

Chatou, , France

Site Status

GSK Investigational Site

Châteauneuf-les-Martigues, , France

Site Status

GSK Investigational Site

Châtenois-les-Forges, , France

Site Status

GSK Investigational Site

Cherbourg - Octeville, , France

Site Status

GSK Investigational Site

Clamart, , France

Site Status

GSK Investigational Site

Clapiers, , France

Site Status

GSK Investigational Site

Clermont-Ferrand, , France

Site Status

GSK Investigational Site

Clermont-Ferrand, , France

Site Status

GSK Investigational Site

Clichy, , France

Site Status

GSK Investigational Site

Colmar, , France

Site Status

GSK Investigational Site

Colomars, , France

Site Status

GSK Investigational Site

Colombelles, , France

Site Status

GSK Investigational Site

Combs-la-Ville, , France

Site Status

GSK Investigational Site

Compiègne, , France

Site Status

GSK Investigational Site

Condé-sur-Noireau, , France

Site Status

GSK Investigational Site

Corbeil-Essonnes, , France

Site Status

GSK Investigational Site

Courpière, , France

Site Status

GSK Investigational Site

Creutzwald, , France

Site Status

GSK Investigational Site

Crolles, , France

Site Status

GSK Investigational Site

Cugnaux, , France

Site Status

GSK Investigational Site

Cusset, , France

Site Status

GSK Investigational Site

Darnétal, , France

Site Status

GSK Investigational Site

Deluz, , France

Site Status

GSK Investigational Site

Dessenheim, , France

Site Status

GSK Investigational Site

Digne-les-Bains, , France

Site Status

GSK Investigational Site

Divonne-les-Bains, , France

Site Status

GSK Investigational Site

Domène, , France

Site Status

GSK Investigational Site

Domont, , France

Site Status

GSK Investigational Site

Draguignan, , France

Site Status

GSK Investigational Site

Einvaux, , France

Site Status

GSK Investigational Site

Esquerdes, , France

Site Status

GSK Investigational Site

Essey-lès-Nancy, , France

Site Status

GSK Investigational Site

Estrées-Saint-Denis, , France

Site Status

GSK Investigational Site

Épinal, , France

Site Status

GSK Investigational Site

Équeurdreville-Hainneville, , France

Site Status

GSK Investigational Site

Évreux, , France

Site Status

GSK Investigational Site

Évry, , France

Site Status

GSK Investigational Site

Fenioux, , France

Site Status

GSK Investigational Site

Feurs, , France

Site Status

GSK Investigational Site

Fécamp, , France

Site Status

GSK Investigational Site

Figeac, , France

Site Status

GSK Investigational Site

Fontaine, , France

Site Status

GSK Investigational Site

Fontaine-lès-Dijon, , France

Site Status

GSK Investigational Site

Fontains, , France

Site Status

GSK Investigational Site

Fontenay-sous-Bois, , France

Site Status

GSK Investigational Site

Forges-les-Eaux, , France

Site Status

GSK Investigational Site

Fouesnant, , France

Site Status

GSK Investigational Site

Foussais-Payré, , France

Site Status

GSK Investigational Site

Francheville, , France

Site Status

GSK Investigational Site

Fumel, , France

Site Status

GSK Investigational Site

Gamarde-les-Bains, , France

Site Status

GSK Investigational Site

Gémozac, , France

Site Status

GSK Investigational Site

Gondecourt, , France

Site Status

GSK Investigational Site

Gonneville-la-Mallet, , France

Site Status

GSK Investigational Site

Gouvieux, , France

Site Status

GSK Investigational Site

Gouy-sous-Bellonne, , France

Site Status

GSK Investigational Site

Gouzeaucourt, , France

Site Status

GSK Investigational Site

Grenoble, , France

Site Status

GSK Investigational Site

Gréoux-les-Bains, , France

Site Status

GSK Investigational Site

Grigny, , France

Site Status

GSK Investigational Site

Guénange, , France

Site Status

GSK Investigational Site

Haguenau, , France

Site Status

GSK Investigational Site

Hatten, , France

Site Status

GSK Investigational Site

Hesdin, , France

Site Status

GSK Investigational Site

Houilles, , France

Site Status

GSK Investigational Site

Houplin-Ancoisne, , France

Site Status

GSK Investigational Site

Hyères, , France

Site Status

GSK Investigational Site

Hœnheim, , France

Site Status

GSK Investigational Site

Illkirch-Graffenstaden, , France

Site Status

GSK Investigational Site

Istres, , France

Site Status

GSK Investigational Site

Jarny, , France

Site Status

GSK Investigational Site

Joué-lès-Tours, , France

Site Status

GSK Investigational Site

L'Aigle, , France

Site Status

GSK Investigational Site

L'Huisserie, , France

Site Status

GSK Investigational Site

La Chapelle-sur-Erdre, , France

Site Status

GSK Investigational Site

La Couronne, , France

Site Status

GSK Investigational Site

La Crèche, , France

Site Status

GSK Investigational Site

La Garenne-Colombes, , France

Site Status

GSK Investigational Site

La Madeleine, , France

Site Status

GSK Investigational Site

La Mézière, , France

Site Status

GSK Investigational Site

La Motte-Servolex, , France

Site Status

GSK Investigational Site

La Source Orleans, , France

Site Status

GSK Investigational Site

La Talaudière, , France

Site Status

GSK Investigational Site

La Voulte-sur-Rhône, , France

Site Status

GSK Investigational Site

Lamarche-sur-Saône, , France

Site Status

GSK Investigational Site

Lambersart, , France

Site Status

GSK Investigational Site

Landivisiau, , France

Site Status

GSK Investigational Site

Lanester, , France

Site Status

GSK Investigational Site

Langon, , France

Site Status

GSK Investigational Site

Laval, , France

Site Status

GSK Investigational Site

Le Barp, , France

Site Status

GSK Investigational Site

Le Bouscat, , France

Site Status

GSK Investigational Site

Le Cannet, , France

Site Status

GSK Investigational Site

Le Chesnay, , France

Site Status

GSK Investigational Site

Le Creusot, , France

Site Status

GSK Investigational Site

Le Havre, , France

Site Status

GSK Investigational Site

Le Kremlin-Bicêtre, , France

Site Status

GSK Investigational Site

Le Lavandou, , France

Site Status

GSK Investigational Site

Le Palais-sur-Vienne, , France

Site Status

GSK Investigational Site

Le Passage D' Agen, , France

Site Status

GSK Investigational Site

Le Rheu, , France

Site Status

GSK Investigational Site

Les Sables-d'Olonne, , France

Site Status

GSK Investigational Site

Les Sables-d'Olonne, , France

Site Status

GSK Investigational Site

Les Ulis, , France

Site Status

GSK Investigational Site

Lesquin, , France

Site Status

GSK Investigational Site

Lille, , France

Site Status

GSK Investigational Site

Limas, , France

Site Status

GSK Investigational Site

Limoges, , France

Site Status

GSK Investigational Site

Lingolsheim, , France

Site Status

GSK Investigational Site

Lisieux, , France

Site Status

GSK Investigational Site

Lognes, , France

Site Status

GSK Investigational Site

Lomme, , France

Site Status

GSK Investigational Site

Loos-en-Gohelle, , France

Site Status

GSK Investigational Site

Lorient, , France

Site Status

GSK Investigational Site

Luzinay, , France

Site Status

GSK Investigational Site

Lyon, , France

Site Status

GSK Investigational Site

Lyon, , France

Site Status

GSK Investigational Site

Lyon, , France

Site Status

GSK Investigational Site

Lyon, , France

Site Status

GSK Investigational Site

Malakoff, , France

Site Status

GSK Investigational Site

Mantes-la-Ville, , France

Site Status

GSK Investigational Site

Marchenoir, , France

Site Status

GSK Investigational Site

Marcq-en-Barœul, , France

Site Status

GSK Investigational Site

Marguerittes, , France

Site Status

GSK Investigational Site

Marmande, , France

Site Status

GSK Investigational Site

Marnay, , France

Site Status

GSK Investigational Site

Marseille, , France

Site Status

GSK Investigational Site

Marseille, , France

Site Status

GSK Investigational Site

Marseille, , France

Site Status

GSK Investigational Site

Marseille, , France

Site Status

GSK Investigational Site

Marseille, , France

Site Status

GSK Investigational Site

Marseille, , France

Site Status

GSK Investigational Site

Martigues, , France

Site Status

GSK Investigational Site

Martin-Église, , France

Site Status

GSK Investigational Site

Martinsart, , France

Site Status

GSK Investigational Site

Mauze Sur Mignon, , France

Site Status

GSK Investigational Site

Meaux, , France

Site Status

GSK Investigational Site

Merkwiller-Pechelbronn, , France

Site Status

GSK Investigational Site

Metz, , France

Site Status

GSK Investigational Site

Meudon, , France

Site Status

GSK Investigational Site

Meylan, , France

Site Status

GSK Investigational Site

Meyssac, , France

Site Status

GSK Investigational Site

Mérignac, , France

Site Status

GSK Investigational Site

Méry-sur-Oise, , France

Site Status

GSK Investigational Site

Mirecourt, , France

Site Status

GSK Investigational Site

Moivrons, , France

Site Status

GSK Investigational Site

Molsheim, , France

Site Status

GSK Investigational Site

Mondeville, , France

Site Status

GSK Investigational Site

Mons-en-Barœul, , France

Site Status

GSK Investigational Site

Montauban, , France

Site Status

GSK Investigational Site

Monteux, , France

Site Status

GSK Investigational Site

Montélimar, , France

Site Status

GSK Investigational Site

Montfermeil, , France

Site Status

GSK Investigational Site

Montgeron, , France

Site Status

GSK Investigational Site

Montigny-le-Bretonneux, , France

Site Status

GSK Investigational Site

Montigny-lès-Metz, , France

Site Status

GSK Investigational Site

Montoire-sur-le-Loir, , France

Site Status

GSK Investigational Site

Montpellier, , France

Site Status

GSK Investigational Site

Montpellier, , France

Site Status

GSK Investigational Site

Montreuil, , France

Site Status

GSK Investigational Site

Morlaàs, , France

Site Status

GSK Investigational Site

Morlaix, , France

Site Status

GSK Investigational Site

Mornas, , France

Site Status

GSK Investigational Site

Mouans-Sartoux, , France

Site Status

GSK Investigational Site

Moutiers Tarentaise, , France

Site Status

GSK Investigational Site

Moyeuvre-Grande, , France

Site Status

GSK Investigational Site

Mur-de-Sologne, , France

Site Status

GSK Investigational Site

Nanterre, , France

Site Status

GSK Investigational Site

Nantes, , France

Site Status

GSK Investigational Site

Nemours, , France

Site Status

GSK Investigational Site

Neuville-sur-Saône, , France

Site Status

GSK Investigational Site

Niort, , France

Site Status

GSK Investigational Site

Nogent-sur-Marne, , France

Site Status

GSK Investigational Site

Noisy-le-Roi, , France

Site Status

GSK Investigational Site

Noyon, , France

Site Status

GSK Investigational Site

Obernai, , France

Site Status

GSK Investigational Site

Oloron-Sainte-Marie, , France

Site Status

GSK Investigational Site

Orléans, , France

Site Status

GSK Investigational Site

Orléans, , France

Site Status

GSK Investigational Site

Orthez, , France

Site Status

GSK Investigational Site

Oucques, , France

Site Status

GSK Investigational Site

Ouistreham, , France

Site Status

GSK Investigational Site

Oust, , France

Site Status

GSK Investigational Site

Ozoir-la-Ferrière, , France

Site Status

GSK Investigational Site

Palaiseau, , France

Site Status

GSK Investigational Site

Pamiers, , France

Site Status

GSK Investigational Site

Paris, , France

Site Status

GSK Investigational Site

Paris, , France

Site Status

GSK Investigational Site

Paris, , France

Site Status

GSK Investigational Site

Paris, , France

Site Status

GSK Investigational Site

Paris, , France

Site Status

GSK Investigational Site

Paris, , France

Site Status

GSK Investigational Site

Paris, , France

Site Status

GSK Investigational Site

Paris, , France

Site Status

GSK Investigational Site

Paris, , France

Site Status

GSK Investigational Site

Paris, , France

Site Status

GSK Investigational Site

Paris, , France

Site Status

GSK Investigational Site

Paris, , France

Site Status

GSK Investigational Site

Paris, , France

Site Status

GSK Investigational Site

Pau, , France

Site Status

GSK Investigational Site

Pau, , France

Site Status

GSK Investigational Site

Pertuis, , France

Site Status

GSK Investigational Site

Pierrefitte-sur-Sauldre, , France

Site Status

GSK Investigational Site

Plouguernével, , France

Site Status

GSK Investigational Site

Pont Ste Maxence, , France

Site Status

GSK Investigational Site

Pont-à-Mousson, , France

Site Status

GSK Investigational Site

Pont-l'Abbé-d'Arnoult, , France

Site Status

GSK Investigational Site

Pontarlier, , France

Site Status

GSK Investigational Site

Pornic, , France

Site Status

GSK Investigational Site

Port-sur-Saône, , France

Site Status

GSK Investigational Site

Provins, , France

Site Status

GSK Investigational Site

Publier, , France

Site Status

GSK Investigational Site

Puteaux, , France

Site Status

GSK Investigational Site

Quévreville-la-Poterie, , France

Site Status

GSK Investigational Site

Râches, , France

Site Status

GSK Investigational Site

Rennes, , France

Site Status

GSK Investigational Site

Rennes, , France

Site Status

GSK Investigational Site

Rennes, , France

Site Status

GSK Investigational Site

Rezé, , France

Site Status

GSK Investigational Site

Rillieux-la-Pape, , France

Site Status

GSK Investigational Site

Riom, , France

Site Status

GSK Investigational Site

Rivery, , France

Site Status

GSK Investigational Site

Roanne, , France

Site Status

GSK Investigational Site

Roche-la-Molière, , France

Site Status

GSK Investigational Site

Rodez, , France

Site Status

GSK Investigational Site

Romainville, , France

Site Status

GSK Investigational Site

Romans-sur-Isère, , France

Site Status

GSK Investigational Site

Romillé, , France

Site Status

GSK Investigational Site

Ronchin, , France

Site Status

GSK Investigational Site

Rosières-en-Santerre, , France

Site Status

GSK Investigational Site

Rouen, , France

Site Status

GSK Investigational Site

Royan, , France

Site Status

GSK Investigational Site

Ruy, , France

Site Status

GSK Investigational Site

Sahurs, , France

Site Status

GSK Investigational Site

Saint-Astier, , France

Site Status

GSK Investigational Site

Saint-Aubin, , France

Site Status

GSK Investigational Site

Saint-Aubin-sur-Scie, , France

Site Status

GSK Investigational Site

Saint-Brevin-les-Pins, , France

Site Status

GSK Investigational Site

Saint-Brieuc, , France

Site Status

GSK Investigational Site

Saint-Chamond, , France

Site Status

GSK Investigational Site

Saint-Chéron, , France

Site Status

GSK Investigational Site

Saint-Cloud, , France

Site Status

GSK Investigational Site

Saint-Cyr-au-Mont-d'Or, , France

Site Status

GSK Investigational Site

Saint-Denis, , France

Site Status

GSK Investigational Site

Saint-Etienne, , France

Site Status

GSK Investigational Site

Saint-Étienne-de-Montluc, , France

Site Status

GSK Investigational Site

Saint-Flour, , France

Site Status

GSK Investigational Site

Saint-Genis-Laval, , France

Site Status

GSK Investigational Site

Saint-Germain-lès-Arpajon, , France

Site Status

GSK Investigational Site

Saint-Herblain, , France

Site Status

GSK Investigational Site

Saint-Ismier, , France

Site Status

GSK Investigational Site

Saint-Jean-de-la-Ruelle, , France

Site Status

GSK Investigational Site

Saint-Leu-la-Forêt, , France

Site Status

GSK Investigational Site

Saint-Louis, , France

Site Status

GSK Investigational Site

Saint-Loup-sur-Semouse, , France

Site Status

GSK Investigational Site

Saint-Nazaire, , France

Site Status

GSK Investigational Site

Saint-Pierre-d'Irube, , France

Site Status

GSK Investigational Site

Saint-Pol-sur-Mer, , France

Site Status

GSK Investigational Site

Saint-Priest, , France

Site Status

GSK Investigational Site

Saint-Rémy-de-Provence, , France

Site Status

GSK Investigational Site

Saint-Tropez, , France

Site Status

GSK Investigational Site

Saintes, , France

Site Status

GSK Investigational Site

Sanary-sur-Mer, , France

Site Status

GSK Investigational Site

Segonzac, , France

Site Status

GSK Investigational Site

Segré, , France

Site Status

GSK Investigational Site

Sens, , France

Site Status

GSK Investigational Site

Septèmes-les-Vallons, , France

Site Status

GSK Investigational Site

Serres, , France

Site Status

GSK Investigational Site

Sélestat, , France

Site Status

GSK Investigational Site

Sillery, , France

Site Status

GSK Investigational Site

Soissons, , France

Site Status

GSK Investigational Site

Sorgues, , France

Site Status

GSK Investigational Site

St-Malo, , France

Site Status

GSK Investigational Site

St.-Jean, , France

Site Status

GSK Investigational Site

Ste Foy La Grande, , France

Site Status

GSK Investigational Site

Ste Maxime, , France

Site Status

GSK Investigational Site

Strasbourg, , France

Site Status

GSK Investigational Site

Strasbourg, , France

Site Status

GSK Investigational Site

Strasbourg, , France

Site Status

GSK Investigational Site

Sucy-en-Brie, , France

Site Status

GSK Investigational Site

Suresnes, , France

Site Status

GSK Investigational Site

Talence, , France

Site Status

GSK Investigational Site

Tarascon, , France

Site Status

GSK Investigational Site

Thiais, , France

Site Status

GSK Investigational Site

Thonon-les-Bains, , France

Site Status

GSK Investigational Site

Thun-Saint-Amand, , France

Site Status

GSK Investigational Site

Toul, , France

Site Status

GSK Investigational Site

Toulon, , France

Site Status

GSK Investigational Site

Toulon, , France

Site Status

GSK Investigational Site

Toulouse, , France

Site Status

GSK Investigational Site

Tours, , France

Site Status

GSK Investigational Site

Trie-Château, , France

Site Status

GSK Investigational Site

Troyes, , France

Site Status

GSK Investigational Site

Vabres-l'Abbaye, , France

Site Status

GSK Investigational Site

Val-de-Vesle, , France

Site Status

GSK Investigational Site

Valence, , France

Site Status

GSK Investigational Site

Vallauris, , France

Site Status

GSK Investigational Site

Vandœuvre-lès-Nancy, , France

Site Status

GSK Investigational Site

Vannes, , France

Site Status

GSK Investigational Site

Vannes, , France

Site Status

GSK Investigational Site

Vaugneray, , France

Site Status

GSK Investigational Site

Vaulx-en-Velin, , France

Site Status

GSK Investigational Site

Vauréal, , France

Site Status

GSK Investigational Site

Vaux-le-Pénil, , France

Site Status

GSK Investigational Site

Vendargues, , France

Site Status

GSK Investigational Site

Vernouillet, , France

Site Status

GSK Investigational Site

Versailles, , France

Site Status

GSK Investigational Site

Vertou, , France

Site Status

GSK Investigational Site

Villars-les-Dombes, , France

Site Status

GSK Investigational Site

Villeblevin, , France

Site Status

GSK Investigational Site

Villeneuve-d'Ascq, , France

Site Status

GSK Investigational Site

Villeurbanne, , France

Site Status

GSK Investigational Site

Villiers-sur-Marne, , France

Site Status

GSK Investigational Site

Vincennes, , France

Site Status

GSK Investigational Site

Viry-Châtillon, , France

Site Status

GSK Investigational Site

Vitrolles, , France

Site Status

GSK Investigational Site

Vitry-sur-Seine, , France

Site Status

GSK Investigational Site

Voreppe, , France

Site Status

GSK Investigational Site

Wattignies, , France

Site Status

GSK Investigational Site

Yerres, , France

Site Status

GSK Investigational Site

Zillisheim, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

113385

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hepatitis B Vaccination in Infants
NCT01896596 COMPLETED PHASE4
The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health Neonates
NCT01183611 COMPLETED PHASE3
A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)
NCT00414050 COMPLETED PHASE3
Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062)
NCT01463683 COMPLETED PHASE3
Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants
NCT00753649 COMPLETED PHASE4
Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.
NCT02697474 COMPLETED PHASE3
Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA
NCT02012998 COMPLETED PHASE3
Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)
NCT00441012 COMPLETED PHASE3
Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations
NCT07243236 RECRUITING
Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b
NCT05401305 COMPLETED PHASE1
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
NCT01353703 COMPLETED PHASE3
Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects
NCT00323050 COMPLETED PHASE3
Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age
NCT00345579 COMPLETED PHASE3
Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy Infants
NCT01226953 COMPLETED PHASE3
Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age
NCT01470287 COMPLETED PHASE3
Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age
NCT01019772 COMPLETED PHASE3
Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth
NCT00317122 COMPLETED PHASE3
To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines
NCT00366366 COMPLETED PHASE3
Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC
NCT00322335 COMPLETED PHASE3
Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)
NCT02759354 COMPLETED PHASE3
A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers
NCT04535037 COMPLETED PHASE4
Communicating Human Papillomavirus Vaccine With Japanese Parents and Caregivers With Daughters Aged 12-18
NCT06347627 ENROLLING_BY_INVITATION NA
Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study
NCT01251133 COMPLETED PHASE3
Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly
NCT01457495 COMPLETED PHASE2
Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b
NCT00734565 COMPLETED PHASE1